Glaucoma

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Glaucoma is defined as a disturbance of the structural or functional integrity of the optic nerve that causes characteristic changes in the optic nerve leading to permanent defects in the visual field. If left untreated, it can lead to blindness. Glaucoma is the leading cause of irreversible blindness throughout the world, and is second only to macular degeneration in the US. Amongst the risk factors, elevated intraocular pressure (IOP), thin corneal thickness (CCT), increasing age, and large cup to disc ratio are established. Concerning its pathogenesis, mechanical and vascular theories are fundamental. In addition, many other mechanisms contribute; such as immune factors, apoptosis, glutamate-induced excitotoxicity, free radicals, nitric acid synthase, and genetic mutations. To assess glaucoma; tonometry, gonioscopy, examination of optic disc, and visual field testing are essential. Animal models for glaucoma have been used to study the pathophysiological basis of glaucoma, aqueous humor dynamics, the trabecular meshwork, the ciliary muscle, and retinal ganglion cells. Animal experiments have provided a worthwhile means of evaluating diagnostic modalities and treatments, both medical and surgical.

Original languageEnglish (US)
Title of host publicationNeuroimmune Pharmacology
PublisherSpringer International Publishing
Pages533-552
Number of pages20
ISBN (Electronic)9783319440224
ISBN (Print)9783319440200
DOIs
StatePublished - Jan 1 2016

    Fingerprint

Keywords

  • Glaucoma
  • Intraocular pressure
  • Optic nerve
  • Retinal ganglion cell

ASJC Scopus subject areas

  • Medicine(all)
  • Immunology and Microbiology(all)
  • Neuroscience(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Havens, S. J., Ghate, D. A., & Gulati, V. (2016). Glaucoma. In Neuroimmune Pharmacology (pp. 533-552). Springer International Publishing. https://doi.org/10.1007/978-3-319-44022-4_35